Insider Legacy Secret
Category

Investing

Category
In Investing

5 Best-performing Canadian Uranium Stocks of 2025

No Comments

The uranium market moved through 2025 with less drama than the previous year, but the quieter tone masked a sector still tightening beneath the surface.

After 2024’s surge to two-decade highs, in 2025, U3O8 prices traded in a narrower US$20 range in 2025, slipping to a low of US$63.71 in March before climbing back toward the mid-US$80s by late September.

In December, spot prices had settled near US$75, a level that has acted as a floor since late summer.

Despite the muted price action, uranium’s underlying drivers strengthened. Long-term demand projections, renewed government backing for nuclear power and rising concerns over supply security all helped support the market.

Investor appetite also played a defining role. Continued buying from the Sprott Physical Uranium Trust (SPUT) (TSX:U.U,OTCQX:SRUUF) and retail investors added steady pressure to the spot market, absorbing millions of pounds of material and lifting prices above where utility demand alone would have placed them.

While true supply shortages did not materialize in 2025, production interruptions and operational uncertainties at major mines made sellers more cautious and prompted utilities to top up inventories more aggressively. The result was a market that remained fundamentally tight, while uranium equities continued to outperform on the strength of a durable, long-term bull thesis.

Against this backdrop, we profile the five best-performing Canadian uranium stocks by share price performance below.

All data was obtained on December 15, 2025, using TradingView’s stock screener. Uranium companies on the TSX, TSXV and CSE with market caps above C$10 million at that time were considered. Read on to learn about the top Canadian uranium stocks in 2025, including what factors have been moving their share prices.

1. North Shore Uranium (TSXV:NSU)

Year-to-date gain: 637.5 percent
Market cap: C$22.17 million
Share price: C$0.295

North Shore Uranium is an exploration company focused on advancing uranium assets in established North American districts. Its core projects include the Falcon and West Bear properties along the eastern margin of Saskatchewan’s Athabasca Basin in Canada, complemented by a growing presence in the Grants uranium district of New Mexico, US.

The company is also evaluating additional exploration opportunities in the United States and Canada as it builds a diversified uranium project portfolio.

In June, North Shore penned a binding term sheet to acquire an up to 87.5 percent interest in the Rio Puerco uranium project in Northwest New Mexico from Resurrection Mining. The project hosts a historical inferred mineral resource estimate, released in 2009, of approximately 11.4 million pounds of U3O8 from 6 million metric tons of ore grading 0.09 percent U3O8 equivalent.

Subsequently, on August 28, the company officially entered into a definitive option agreement for the acquisition and closed a C$1.4 million private placement. On September 11, the company announced it staked 27 additional mining claims at the Rio Puerco project, bolstering its holdings in the area to 64 adjoining Bureau of Land Management claims.

As for its projects in Canada, in an October press release North Shore announced the completion of a prospecting program at its Falcon property, during which crews evaluated 18 priority targets for surface expression and anomalous radioactivity, collecting samples to support further exploration.

Later in the month, North Shore fulfilled its final earn-in requirement at the West Bear property, issuing C$50,000 shares to Gem Oil to secure the right to acquire a 75 percent interest in the project.

Shares of North Shore Uranium rose to a year-to-date high of C$0.29 on December 15, a few days after the company launched a C$3 million private placement on December 11.

Looking ahead, the company is planning a drill program at the Rio Puerco uranium project during H1 2026.

2. Energy Fuels (TSX:EFR)

Year-to-date gain: 156.12 percent
Market cap: C$4.76 billion
Share price: C$19.26

US-based uranium producer Energy Fuels has a large portfolio of conventional and in-situ recovery (ISR) projects across the Western US, including Pinyon Plain in Arizona, a top national producer.

Additionally, Energy Fuels owns and operates the White Mesa mill, the only fully licensed and operating conventional uranium mill in the US. The company is progressing heavy rare earth oxide processing at the plant as well.

Company shares reached a year-to-date high of C$36.84 on October 14, 11 days after Energy Fuels closed its US$700 million offering of 0.75 percent convertible senior notes due 2031, which was upsized after initial purchasers exercised their option to purchase a further US$100 million in notes.

In a Q3 report released on November 3, the company underscored a rise in uranium sales, as its low-cost US production continued to outperform, putting the miner on track to exceed its 2025 guidance.

The firm also advanced its rare earth ambitions, producing 29 kilograms of dysprosium oxide in pilot runs through September, with terbium oxide next in line.

The October US$700 million convertible note offering strengthened the balance sheet, lifting working capital to nearly US$1 billion and raising the effective conversion price to US$30.70 per share.

3. Stallion Uranium (TSXV:STUD)

Year-to-date gain: 150 percent
Market cap: C$49.57 million
Share price: C$0.375

Uranium junior Stallion Uranium holds a 2,870 square kilometer land package on the western side of the Athabasca Basin, in Saskatchewan, Canada, including a joint venture with Atha Energy (TSXV:SASK,OTCQB:SASKF) for the largest contiguous project in the region. The company’s primary focus is the Coyote target at the Moonlite project.

Stallion’s share price shot upward on July 8 after the company announced a technology data acquisition agreement for Matchstick TI, an intelligent geological target identification platform with 77 percent accuracy. Stallion plans to use the technology to enhance its exploration efforts. It closed the acquisition on November 12.

In early September, Stallion Uranium closed the final tranche of a non-brokered private placement, raising gross proceeds of C$10.49 million. The financing included 22.3 million non-flow-through units and 30.1 million flow-through units, both priced at $0.20 per unit.

Stallion’s shares registered a year-to-date high of C$0.51 on September 16.

According to an October statement, Stallion planned to start a high-resolution ground time domain electromagnetic survey on Coyote on November 1, but it has not yet released a further update on the survey.

The company announced a further private placement on December 12, this one consisting of flow-through shares for gross proceeds of C$4.55 million at a price of C$0.45 per share.

4. District Metals (TSXV:DMX)

Year-to-date gains: 139.51 percent
Market cap: C$165.24 million
Share price: C$0.97

District Metals is an energy metals and polymetallic explorer and developer with a portfolio of seven assets in Sweden, including four uranium projects: Viken, Ardnasvarre, Sågtjärn and Nianfors. Currently, District is focused on its Viken uranium-vanadium project, which it says hosts the world’s largest undeveloped uranium deposit.

Shares began trending upwards in mid-May following news of a fully subscribed C$6 million private placement.

District spent 2025 advancing its four uranium projects through a series of targeted surveys. A helicopter-borne mobile magnetotellurics (MobileMT) program wrapped up at the flagship Viken property in June, followed by drone-based radiometric and magnetic surveys at Ardnasvarre, Sågtjärn and Nianfors in July.

Early September results at Sågtjärn and Nianfors were strong enough for the company to seek expanded licenses. Later that month, new MobileMT data from Viken revealed large low-resistivity anomalies both within and beyond the known deposit footprint, pointing to potential for additional uranium deposits.

Shares of District rallied to a year-to-date high of C$1.53 on October 15, the day the company released the results of its radiometric and magnetic survey at the Ardnasvarre property, which identified strong and large anomalies associated with uranium polymetallic occurrences.

District also reported fresh momentum at its alum shale properties after completing airborne MobileMT surveys across the Österkälen, Tåsjö and Malgomaj licenses this summer.

The first batch of results, released in late October, outlined a significant new geophysical anomaly at its wholly owned Österkälen license. District has already applied for an adjacent mineral license to capture the anomaly’s northwestern extension. The Österkälen area lies roughly 100 kilometers northeast of the company’s flagship Viken property.

In subsequent announcements, District reported the discovery of high priority targets at the Tåsjö alum shale property, and of large, robust targets at the Malgomaj alum shale property, both of which led the company to file applications for adjacent mineral licenses.

In early November, District Metals welcomed a landmark decision in Sweden when Parliament voted to repeal the country’s 2018 moratorium on uranium exploration and mining.

The new legislation, set to take effect January 1, 2026, opens the door for renewed development in a nation that holds roughly 27 percent of Europe’s known uranium resources.

5. Purepoint Uranium (TSXV:PTU)

Year-to-date gain: 113.64 percent
Market cap: C$38.01 million
Share price: C$0.47

Exploration company Purepoint Uranium has an extensive uranium portfolio including six joint ventures and five wholly owned projects, all located in Saskatchewan’s Athabasca Basin.

In January, Purepoint strengthened its relationship with IsoEnergy (TSX:ISO,NYSEAMERICAN:ISOU) when the latter exercised its put option under the framework of a previously announced joint-venture agreement, transferring 10 percent of its stake to Purepoint in exchange for 4 million shares. The now 50/50 joint venture will explore 10 uranium projects across 98,000 hectares in the Athabasca Basin, including the Dorado project.

As for Q3, the company closed the final tranche of a C$6 million private placement on September 5.

Later in the month, Purepoint released partial assay results from the Dorado project for one hole from its 11 hole drill program. The drill hole returned the most significant intervals to date, according to the company, with one interval of 2.1 meters grading 1.6 percent U3O8, including 0.4 meters at 8.1 percent, as well as another interval of 4.9 meters at 0.52 percent. The company has since dubbed this the Nova discovery

Purepoint ended September by launching its inaugural drill program at the Tabbernor project, located on the southeastern edge of the basin. The program, which concluded in November, targeted a 60 kilometer long corridor of graphitic conductors with five first-pass diamond drill holes. The Tabbernor findings will be combined with the company’s ongoing regional interpretation work to prioritize next targets.

Shares of Purepoint registered a year-to-date high of C$0.80 on October 14 as uranium prices rose.

In early December, Purepoint and IsoEnergy approved an expanded 2026 exploration program at the Dorado project following the previously released strong drill results, which Purepoint said confirm ‘a steeply dipping, uranium-bearing structure that remains open in all directions.’

The joint venture will prioritize the northeastern extension of the Nova discovery while advancing other high-potential zones across Dorado.

FAQs for investing in uranium

What is uranium used for?

Uranium is primarily used for the production of nuclear energy, a form of clean energy created in nuclear power plants. In fact, 99 percent of uranium is used for this purpose. As of 2022, there were 439 active nuclear reactors, as per the International Atomic Energy Agency. In 2023, 9 percent of US power came from nuclear energy.

The commodity is also used in the defense industry as a component of nuclear weaponry, among other uses. However, there are safeguards in effect to keep this to a minimum. To create weapons-grade uranium, the material has to be enriched significantly — above 90 percent — to the point that to achieve just 5.6 kilograms of weapons-grade uranium, it would require 1 metric ton of uranium pre-enrichment.

Because of this necessity, uranium enrichment facilities are closely monitored under international agreements. Uranium used for nuclear power production only needs to be enriched to 5 percent; nuclear enrichment facilities need special licenses to enrich above that point for uses such as research at 20 percent enrichment.

The metal is also used in the medical field for applications such as transmission electron microscopy. Before uranium was discovered to be radioactive, it was used to impart a yellow color to ceramic glazes and glass.

Where is uranium found?

The country with the greatest uranium reserves by far is Australia — the island nation holds 28 percent of the world’s uranium reserves. Rounding out the top three are Kazakhstan with 15 percent and Canada with 9 percent.

Although Australia has the highest reserves, it holds uranium as a low priority and is only fourth overall for production. All its uranium output is exported, with none used for domestic nuclear energy production.

Kazakhstan is the world’s largest producer of the metal, with production of 21,227 metric tons in 2022. The country’s national uranium company, Kazatomprom, is the world’s largest producer.

Canada’s uranium reserves are found primarily in its Athabasca Basin, and the region is a top producer of the metal as well.

Why should I buy uranium stocks?

Investors should always do their own due diligence when looking at any commodity so that they can decide whether it fits into their investment plans. With that being said, many experts are convinced that uranium has entered into a significant bull market, meaning that uranium stocks could be a good buy.

A slew of factors have led to this bull market. Discourse has been building around the metal’s use as a source of clean energy, which is important for countries looking to reach climate goals, and interest in nuclear power to fuel artificial intelligence energy demand has increased significantly as well.

Nations are now prioritizing a mix of clean energies such as solar and wind energy alongside nuclear. Significantly, in August 2022, Japan announced it is looking into restarting its idled nuclear power plants and commissioning new ones.

Uranium prices are very important to uranium miners, and levels had not been high enough for production to be economic. However, prices have climbed significantly in recent years, and spiked from US$58 per pound in August 2023 to a high of US$106 per pound in February 2024.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com
by
Read More
In Investing

Freegold Ventures Limited Announces $30 Million Brokered Private Placement Financing

No Comments

/NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA/

 Freegold Ventures Limited (TSX: FVL,OTC:FGOVF) (OTCQX: FGOVF) (the ‘Company’ or ‘Freegold Ventures’), is pleased to announce that it has entered into an agreement with Paradigm Capital Inc. (‘Paradigm’), pursuant to which Paradigm will act as lead agent and sole bookrunner on behalf of a syndicate of agents (together with Paradigm, the ‘Agents’) to be formed in connection with a proposed brokered ‘best efforts’ private placement financing (the ‘Offering’) for total gross proceeds of $30,000,100, consisting of 23,077,000 common shares of the Company (the ‘Common Shares’) at a price of $1.30 per Common Share (‘Issue Price’).

The Company will grant the Agents an option (the ‘Agents’ Option‘) to sell up to that number of additional Common Shares equal to 15% of the base Offering size, exercisable, by notice in writing to the Company, at any time not less than 48 hours prior to the Closing Date.

The net proceeds from the Offering will be used to complete a Pre-Feasibility Study for the Golden Summit Project, to support ongoing exploration, and for general corporate and working capital purposes. Management believes that these funds will further strengthen the Company’s ability to advance the Golden Summit Project as it moves the project through the pre-feasibility stage.

The Common Shares will be offered for sale pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (the ‘Listed Issuer Financing Exemption‘), to purchasers resident in each of the provinces of Canada (other than Québec), and in other qualifying jurisdictions outside of Canada that are mutually agreed to by the Company and the Agents pursuant to relevant prospectus or registration exemptions in accordance with applicable laws. As the Offering is being completed pursuant to the Listed Issuer Financing Exemption, the Common Shares issued in the Offering will not be subject to a hold period in Canada pursuant to applicable Canadian securities laws.

There is an offering document related to this Offering that can be accessed under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.freegoldventures.com. Prospective investors should read this offering document before making an investment decision.

The Offering is expected to close on or about January 6, 2026 (the ‘Closing Date‘) and will be subject to regulatory approvals and customary closing conditions, including listing of the Common Shares on the Toronto Stock Exchange.

The Agents will be entitled to, on the Closing Date, a cash commission equal to 5% of the gross proceeds of the Offering including on any exercise of the Agents’ Option.

The securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any U.S. state securities laws, and may not be offered or sold in the United States without registration under the U.S. Securities Act and all applicable state securities laws or compliance with the requirements of an applicable exemption therefrom. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor may there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Freegold Ventures Limited

Freegold Ventures is a TSX-listed company focused on exploration in Alaska.

Forward-looking Information Cautionary Statement

This press release contains statements that constitute ‘forward-looking information’ (collectively, ‘forward-looking statements’) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this press release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as ‘expects’, or ‘does not expect’, ‘is expected’, ‘anticipates’ or ‘does not anticipate’, ‘plans’, ‘budget’, ‘scheduled’, ‘forecasts’, ‘estimates’, ‘believes’ or ‘intends’ or variations of such words and phrases or stating that certain actions, events or results ‘may’ or ‘could’, ‘would’, ‘might’ or ‘will’ be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements contained in this press release, include, without limitation, statements regarding the receipt of TSX final approval for the Offering and the use of proceeds from the Offering. In making the forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurance that the expectations of any forward-looking statements will prove to be correct. Known and unknown risks, uncertainties, and other factors may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: availability of financing; delay or failure to receive required permits or regulatory approvals; and general business, economic, competitive, political and social uncertainties. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise. See Freegold’s Annual Information Form for the year ended December 31, 2024, filed under Freegold’s profile at www.sedarplus.ca, for a detailed discussion of the risk factors associated with Freegold’s operation.

SOURCE Freegold Ventures Limited

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2025/18/c0220.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com
by
Read More
In Investing

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

No Comments

The long-debated issue of US cannabis rescheduling is finally back in the spotlight.

On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now assessing what such a shift could mean for the industry, from taxation and access to broader investment potential.

What do industry experts think about cannabis rescheduling?

Sasha Nutgent, vice president of cannabis retail, Housing Works Cannabis

As it stands today with the current classification, retailers are not incentivized to operate legally. Reclassification would change that for thousands of businesses, especially those owned by folks from communities most impacted by the war on drugs.

Anthony Coniglio, CEO of NewLake Capital Partners (OTCQX:NLCP)

We welcome President Trump’s directive to the Department of Justice to finalize the rescheduling of cannabis from Schedule I to Schedule III. This represents a historic and long-overdue alignment of federal policy with scientific evidence, medical practice and the regulatory reality already functioning across most US states.

Now, follow through is critical. We urge the DOJ and DEA to move swiftly to issue the Final Rule and complete the rescheduling process. Doing so would finally remove the punitive burden of Section 280E, allowing compliant, state-licensed operators to reinvest in growth, innovation and workforce development across the nearly half-million Americans employed in this industry. This is not about legalization — it’s about legitimacy. Responsible operators have long followed strict state-level compliance frameworks that prioritize safety, transparency and consumer protection. Rescheduling would rightfully distinguish these businesses from illicit markets and allow federal enforcement to focus where it truly belongs: on criminal cartels, not compliant small businesses. This announcement is a milestone, not a finish line. Congress must build on this momentum by passing the bipartisan SAFER Banking Act and advancing STATES 2.0 to create a durable national framework that strengthens safety, access and accountability for all stakeholders.

Harrison Bard, CEO and co-founder, Custom Cones USA and DaySavers

Rescheduling will further stack the odds against small operators, but this type of change is a long-overdue step toward treating cannabis like the legitimate medicine so many veterans already rely on. For years they’ve been forced to navigate stigma, inconsistent access and out-of-pocket costs just to manage pain, PTSD and other service-related conditions. A more rational federal framework won’t solve everything, but it moves us closer to the kind of recognition, research and support our veterans deserve. At DaySavers, we’ve tried to honor that community in our own small way through our ‘Cones for a Cause’ line, which sends a portion of proceeds directly to the Weed for Warriors Project. Veterans have carried the weight for the rest of us; it’s time our policies — and our industry — carry some of it back.

Chris Fontes, founder and CEO, High Spirits

While any incremental progress for normalizing cannabis is worth celebrating, Schedule III is not the savior the industry believes it to be. The requirements for legal participation in a Schedule III market are burdensome, and it’s unlikely that any significant portion of the industry will be able to properly participate.

Relief from 280e is exciting, but selling a Schedule III drug without drug approval, licensure, etc. is still quite illegal. Sadly, this will not be the win the industry wants it to be, and much more work is yet to be done. Further, let’s not forget we already have some version of cannabis that is completely descheduled, and we’re still fighting to keep it that way.

Therefore, we should be cautious to simultaneously celebrate marijuana moving to Schedule III while also ignoring — or in some cases, celebrating — the rescheduling of hemp products that are currently off the schedule all together.

Will cannabis rescheduling improve access to banking?

Sierra Elaina, CEO, Lehua Brands

Rescheduling cannabis would be a turning point for an industry that’s been operating under impossible conditions. Treating cannabis as a Schedule I drug has restricted banking, crushed margins through unfair tax rules and prolonged stigma that no longer reflects reality. This change could finally legitimize cannabis as a regulated business — one with access to banking, fair taxation and a path forward for operators who have been hanging on by a thread.

Terry Mendez, CEO, Safe Harbor Financial

President Trump’s rescheduling cannabis by executive order marks a significant shift in tone from Washington and a meaningful moment for an industry long stuck in legal limbo. Reclassifying cannabis as Schedule III would acknowledge its medical legitimacy and begin to correct a half-century of misguided federal policy.

That said, rescheduling is not reform. The core challenges around cannabis banking such as compliance burdens, cash dependency and regulatory uncertainty would remain unchanged. The industry would still fall under the Bank Secrecy Act, with all its reporting and monitoring obligations intact. This moment is likely to invite broader interest from financial institutions, but without structural reform or updated guidance, many will remain cautious. A true fix requires a coordinated federal framework that aligns financial policy with the realities of a US$38 billion state-legal industry. Any step forward is welcome, but incremental progress should not be mistaken for a comprehensive solution. The cannabis sector deserves financial clarity, not just legal signals.

Ryan Hunter, chief revenue officer, Spherex

Cannabis is still federally illegal — but even as a federally illegal substance — the move to Schedule III dramatically reduces the federal tax burden for operators. Under IRS code 280E, handling Schedule I or Schedule II substances eliminates the ability for operators to deduct standard operating expenses that most other businesses deduct from their federal taxes. As a result of 280E, cannabis operators’ effective tax rate may be as high as 80 percent.

Beyond this significant improvement, the implications are unclear, but we’re hopeful that this move will allow for cannabis operators to garner the same investment opportunities other industries will enjoy.

Joe Gerrity, CEO, Crescent Canna

If marijuana is reclassified to Schedule III, it immediately strengthens the regulated marijuana industry by eliminating 280E and recognizing legitimate medical uses — but the more important ripple effect is what it means for hemp. With hemp THC products set to be effectively banned next November without new legislation, a federal move to loosen restrictions on marijuana while simultaneously eliminating a thriving hemp market is completely illogical and contradictory. Reclassification increases the likelihood that Congress and the federal government will move toward a coherent framework that keeps hemp products legal but properly regulated.

Mark Lewis, president of Specialty Payments, Lüt

Make no mistake, rescheduling is just the beginning for those working in the cannabis industry. Until the SAFE Banking Act or 280E is passed, operators will still have to jump through challenging financial hoops to pay their staff, bills or garner investment. The moment is historic, but until cannabis businesses can operate fiscally with the same ease as any other business, more work needs to be done.

Payments still need to work in the reality of today, where the ongoing threat of card network shutdowns exists, not just the promise of future reform. While rescheduling may open doors over time, it does not remove the day-to-day financial friction that cannabis operators face right now.

Lüt is uniquely positioned to support the cannabis industry and help businesses grow safely, compliantly and confidently.

Adam Stettner, CEO, FundCanna

Rescheduling cannabis to Schedule III will deliver immediate, measurable impacts. Most notably, it eliminates Section 280E from the federal tax equation for licensed operators — a change that, for many, is the difference between treading water and turning a profit. It also unlocks long-blocked research pathways, enabling rigorous clinical studies, standardized formulations, and a new era of product innovation.

Additionally, it has catalyzed a broader shift across the industry pushing cannabis businesses to adopt more institutional practices around banking, compliance, financial reporting and governance.

What would rescheduling mean for medical cannabis?

Ryan Hunter, chief revenue officer, Spherex

The real win here is for medical cannabis. By moving cannabis to Schedule III, Cannabis will be treated similarly to ketamine, Tylenol + Codeine and anabolic steroids — all drugs that have been approved by the FDA for use with a doctor’s prescription. Not only will those in states without medical cannabis programs gain access, but as markets evolved to recreational programs, many remedies for patients have been left behind due to the dramatically larger demand for adult use products relative to medical products. At Schedule III, it’s much more practical for mainstream physicians to prescribe cannabis products.

Alex Gonzalez, president and co-founder, Calyx Containers

Whenever the White House moves forward with Schedule III, the federal government is effectively telling us that cannabis is medicine. And if it’s medicine, ‘good enough’ cannabis practices won’t cut it anymore. Whether rescheduling happens next month or next year, the direction is clear: cannabis is moving toward pharma-grade standards. For brands, that means tightening quality systems, investing in the ability to react or scale and preparing for a regulatory-ready supply chain. We’re seeing the smart operators on shoring infrastructure and we’re positioning our domestic production and business model on being ready to help operators turn this moment into a competitive advantage.

Mark Lewis, president of specialty payments, Lüt

Rescheduling is the single most important drug policy move in decades. The potential opportunities for medical and scientific research will significantly increase, while those living in states without an existing medical program will now have access to the powerful healing properties of the plant.

Ali Garawi, co-founder, CEO and CFO, Muha Meds

If Trump moves to reschedule cannabis, it would be a long-overdue acknowledgment that this plant never belonged in the most restrictive drug category. Cannabis has centuries of real-world use behind it for pain management, appetite and sleep, yet it has been trapped in a legal framework built on fear, stigma and misinformation. Federal prohibition hasn’t protected consumers — it has only created impossible hoops for legitimate businesses to jump through.

While cannabis should be entirely descheduled, rescheduling is an important move forward. It would create space for common-sense regulation, banking access, medical research and consumer protections that should have existed years ago. For consumers, that means safer products, better testing standards, more consistent access and pricing that reflects a functioning, regulated market rather than prohibition-era risk.

At a time when the country is facing an ongoing overdose and mental health crisis, continuing to treat cannabis as a threat is nonsensical. Rescheduling would not solve everything, but it would be a meaningful step toward replacing outdated ideology with education, safety and public health reality.

Josh Kesselman, publisher, High Times Magazine; founding force behind RAW Rolling Papers

I, among others in the industry, are very concerned that Trump’s news of rescheduling is a false flag!

Moving THC to Schedule III would allow big pharma to launch their synthetic THC pills available by prescription only at huge costs and subject current dispensaries to a whole new set of felonies under the FDCA (Food and Drug Cosmetic Act). These “new” federal crimes include selling a prescription drug without a license, dispensing a drug without a prescription, misbranding a drug, illegal distribution, conspiracy and more!

In fact, the penalties under Schedule III actually increase, not decrease, depending on what a federal prosecutor chooses to charge a seller or grower with.

Gennaro Luce, founder and CEO, CannaLnx, powered by EM2P2

Rescheduling is an important and overdue shift for patient-centric healthcare, but the move to Schedule III alone isn’t enough to make medical cannabis more accessible or affordable. Schedule III puts cannabis in the same drug class as certain types of Tylenol, but what does that mean for patients? We hope it means more will be able to access their medicine through insurance plans and traditional doctors.

But insurers still need verification, compliance and eligibility frameworks before they can treat medical cannabis like a real benefit. That part of the system is still missing from the national conversation — fortunately, it’s the medical-cannabis system piece we’ve already built and tested alongside physicians, patients, dispensaries, POS systems and insurers.

Gibran Washington, CEO, Ethos

Rescheduling cannabis from Schedule I to Schedule III is a long-overdue acknowledgment of what patients, providers and responsible operators have known for years: this plant has real therapeutic value, and the current federal posture has been holding progress back. Rescheduling won’t fix every challenge in front of us, but it finally moves us in the right direction opening clearer pathways for research, easing unnecessary barriers for patients and creating a more functional regulatory environment for operators who are doing this the right way.

At Ethos, our commitment has always been to education, science and access. This shift should be the beginning of broader reforms that address affordability, equity and the stigma that still shadows this industry. If done thoughtfully, rescheduling can be a catalyst for a more transparent, patient-centered and responsible cannabis ecosystem.

JP Doran, CEO, Crucial Innovations

We applaud the US government for undertaking the most significant reform in federal cannabis policy since the 1970s. While rescheduling stops short of full federal legalization, it meaningfully reduces research barriers, modernizes regulatory oversight and formally acknowledges the medical value of cannabis within federal policy.

Because this development comes from the world’s largest pharmaceutical market, its impact extends far beyond US borders. It is expected to catalyze international momentum, encouraging regulators in the UK, EU, South Africa and other emerging markets to revisit outdated frameworks, align with evolving scientific evidence and create clearer pathways for medical cannabis innovation. Greater regulatory convergence will help unlock cross-border research, harmonize quality standards and expand patient access globally. As global markets respond to this shift, rescheduling stands to accelerate the development, approval and international distribution of next-generation cannabis-based medicines. We welcome reforms that advance transparency, safety and patient access, and we look forward to contributing to a more connected, science-driven global cannabis ecosystem.

Betty Aldworth, co-executive director, MAPS; chair of the Marijuana Policy Project

The recently reported intent to reschedule cannabis by executive order marks a symbolic victory and a recalibration of decades of federal misclassification. If enacted, reclassifying cannabis as a Schedule III substance would be a long-overdue acknowledgment of its medical utility and a sharp rhetorical shift from Washington.

But symbolism is not structural reform. Rescheduling alone will not untangle the web of barriers facing cannabis consumers and the industry that serves them. It will not resolve the profound dangers of cash-only operations. It will not eliminate the risks to cannabis consumers embedded in housing policy, immigration policy, workplace drug testing, or family law. It will not establish the regulatory clarity required for millions of patients to receive insurance coverage when they choose cannabis over pharmaceutical interventions that may offer less benefit or carry greater risk.

This moment will generate headlines and optimism, but without comprehensive federal reform to address continued criminal sanctions, collateral consequences and financial obstructions faced by cannabis businesses, the communities most impacted by prohibition will continue to face disproportionate barriers.

Cannabis regulation is not a fringe experiment — it is a $38 billion economic engine operating under state-legal frameworks in nearly half of the country that has delivered overall positive social, educational, medical and economic benefits, including correlation with reductions in youth use in states where it’s legal. Cannabis policy must catch up to political reality. Anything less is not reform. It’s a delay.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com
by
Read More
In Investing

Pinnacle Closes First Tranche of Private Placement

No Comments

(TheNewswire)

Pinnacle Silver and Gold Corp.

Finders’ Fees consisting of $2,940 in cash commission and 21,000 non-transferable finders’ warrants were paid in connection with the Offering.  Each finder’s warrant entitles the holder to acquire one common share at $0.20 cents per share over a 24-month period.  

The net proceeds raised from the Offering will be used to advance the high-grade El Potrero gold-silver project in Durango, Mexico, for project evaluations, and for general working capital.

Insiders of the Company participated in the first tranche, subscribing for a total of 600,000 units and gross proceeds of $84,000.  The participation of the insiders in the Offering will constitute a related-party transaction for the purposes of Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions).  The Company is exempt from the requirements to obtain a formal evaluation or minority shareholder approval in connection with the insider participation in reliance on sections 5.5(a) and 5.7(1)(a) of MI 61-101 as neither the fair market value of the securities issued, nor the fair market value of the consideration for the securities issued will exceed 25 per cent of the company’s market capitalization as calculated in accordance with MI 61-101.  

All securities to be issued will be subject to a four-month hold period from the date of issuance and subject to TSX Venture Exchange approval.  The securities offered have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

The Company expects to complete the second and final tranche of the Offering by January 30, 2026.

About the Potrero Property

El Potrero is located in the prolific Sierra Madre Occidental of western Mexico and lies within 35 kilometres of four operating mines, including the 4,000 tonnes per day (tpd) Ciénega Mine (Fresnillo), the 1,000 tpd Tahuehueto Mine (Luca Mining) and the 250 tpd Topia Mine (Guanajuato Silver).

High-grade gold-silver mineralization occurs in a low sulphidation epithermal breccia vein system hosted within andesites of the Lower Volcanic Series and has three historic mines along a 500 metre strike length.  The property has been in private hands for almost 40 years and has never been systematically explored by modern methods, leaving significant exploration potential.

A previously operational 100 tpd plant on site can be refurbished / rebuilt and historic underground mine workings rehabilitated at relatively low cost in order to achieve near-term production once permits are in place. The property is road accessible with a power line within three kilometres.  

Pinnacle will earn an initial 50% interest immediately upon commencing production.  The goal would then be to generate sufficient cash flow with which to further develop the project and increase the Company’s ownership to 100% subject to a 2% NSR.  If successful, this approach would be less dilutive for shareholders than relying on the equity markets to finance the growth of the Company.

About Pinnacle Silver and Gold Corp.

Pinnacle is focused on the development of precious metals projects in the Americas.  The high-grade Potrero gold-silver project in Mexico’s Sierra Madre Belt hosts an underexplored low-sulphidation epithermal vein system and provides the potential for near-term production. In the prolific Red Lake District of northwestern Ontario, the Company owns a 100% interest in the past-producing, high-grade Argosy Gold Mine and the adjacent North Birch Project with an eight-kilometre-long target horizon.  With a seasoned, highly successful management team and quality projects, Pinnacle Silver and Gold is committed to building long-term, sustainable value for shareholders.

Signed: ‘Robert A. Archer’

President & CEO

For further information contact:

Email:        info@pinnaclesilverandgold.com

Tel.:  +1 (877) 271-5886 ext. 110

Website: www.pinnaclesilverandgold.com

 

Neither the TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

   

Copyright (c) 2025 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

This post appeared first on investingnews.com
by
Read More
In Investing

RETRANSMISSION: LaFleur Minerals Upsizes LIFE and Flow-Through Unit Offerings

No Comments

LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’ or ‘Issuer’) announces it has amended its previously disclosed non-brokered private placement offering, upsizing it to up to 9,000,000 units of the Company (the ‘Units’) at a price of $0.50 per Unit gross proceeds of up to $4,500,000 (the ‘LIFE Offering’). Each Unit will consist of one (1) common share in the capital of the Company (each a ‘Common Share’) and one (1) Common Share purchase warrant (a ‘Warrant’) granting the holder the right to purchase one (1) additional Common Share of the Company (a ‘Warrant Share’) at a price of $0.75 at any time on or before 36 months from the Closing Date (defined below). The Warrants will no longer be subject to an accelerated expiry, as was previously announced in the Company’s press release dated December 15, 2025.

The gross proceeds from the LIFE Offering will be used for the commissioning and restart of gold production operations at the Company’s wholly-owned Beacon Gold Mine and Mill, as well as work at the Company’s Swanson Gold Project in Quebec and for and general working capital purposes.

The Units will be offered for sale pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by CSA Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption, to purchasers resident in Canada, excluding Quebec, and other qualifying jurisdictions.

The securities offered under the LIFE Offering will not be subject to a hold period in accordance with applicable Canadian securities laws. There is an offering document (the ‘Offering Document‘) related to the LIFE Offering that can be accessed under the Issuer’s profile at www.sedarplus.ca and at the Company’s website at www.lafleurminerals.com. Prospective investors should read this Offering Document before making an investment decision.

The terms of the Company’s previously announced flow-through offering (‘FT Offering’) have not changed, refer to the Company’s press release dated December 15, 2025 for more information.

The Company has agreed to pay qualified finders and brokers a cash commission of 7.0% of the aggregate gross proceeds of the LIFE Offering and FT Offering and such number of broker warrants (the ‘Broker Warrants‘) as is equal to 7.0% of the number of Units sold under the LIFE Offering and FT Offering. Each Broker Warrant will entitle the holder to purchase one Common Share at an exercise price equal to the Offering Price for a period of 24 months following the Closing Date.

The closing of the LIFE Offering and FT Offering is expected to occur on or about December 31, 2025 (the ‘Closing Date‘), or such other earlier or later date as the Company may determine.

The Company continues to progress in the closing of its previously announced brokered private placement of gold-linked convertible notes, as announced on November 5, 2025, a financing that aims to raise up to C$7 million to fund the restart of the company’s Beacon Gold Mill in Val d’Or, Quebec.

This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act’), and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent an exemption from registration under the U.S. Securities Act and applicable U.S. state securities laws. ‘United States’ and ‘U.S. person’ are as defined in Regulation S under the U.S Securities Act.

About LaFleur Minerals Inc.

LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (FSE: 3WK0) is focused on the development of district-scale gold projects in the Abitibi Gold Belt near Val-d’Or, Québec. Our mission is to advance mining projects with a laser focus on our resource-stage Swanson Gold Deposit and the Beacon Gold Mill, which have significant potential to deliver long-term value. The Swanson Gold Project is approximately 18,304 hectares (183 km2) in size and includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. LaFleur has recently consolidated a large land package along a major structural break that hosts the Swanson, Bartec, and Jolin gold deposits and several other showings which make up the Swanson Gold Project. The Swanson Gold Project is easily accessible by road allowing direct access to several nearby gold mills, further enhancing its development potential. Lafleur Mineral’s fully refurbished and permitted Beacon Gold Mill is capable of processing over 750 tonnes per day and is being considered for processing mineralized material at Swanson and for custom milling operations for other nearby gold projects.

ON BEHALF OF LaFleur Minerals INC.

Paul Ténière, M.Sc., P.Geo.
Chief Executive Officer
E: info@lafleurminerals.com
LaFleur Minerals Inc.
1500-1055 West Georgia Street
Vancouver, BC V6E 4N7

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this news release.

Cautionary Statement Regarding ‘Forward-Looking’ Information

This news release includes certain statements that may be deemed ‘forward-looking statements’. All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words ‘expects’, ‘plans’, ‘anticipates’, ‘believes’, ‘intends’, ‘estimates’, ‘projects’, ‘potential’ and similar expressions, or that events or conditions ‘will’, ‘would’, ‘may’, ‘could’ or ‘should’ occur. Forward-looking statements in this news release include, without limitation, statements related to the closing of the LIFE Offering and the FT Offering, and the anticipated use of proceeds from the LIFE Offering and the FT Offering. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278557

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com
by
Read More
In Investing

Silver Dollar Resources

No Comments

Investor Insight

Silver Dollar Resources is repositioning its flagship La Joya silver-gold-copper project to unlock high-grade underground potential in Mexico’s prolific Durango-Zacatecas silver belt. Strengthened by the all-share sale of its Ranger-Page project to Bunker Hill Mining, the company offers investors leveraged exposure to near-term silver (zinc-lead) production in Idaho’s Silver Valley, while remaining fully funded to advance exploration across its core portfolio through 2026.

Overview

Silver Dollar Resources (CSE:SLV,OTCQX:SLVDF,FSE:4YW) is a precious metals exploration company focused on advancing high-grade silver and gold opportunities in Mexico. The company’s primary asset is the La Joya silver-gold-copper project, located in the southern portion of the Durango-Zacatecas silver belt, one of the world’s most productive silver regions.

La Joya has been the subject of extensive historical exploration, including more than 51,600 meters of drilling across 182 drill holes. This work outlined multiple mineralized zones, including the Main Mineralized Trend, Santo Niño and Coloradito. Silver Dollar is re-evaluating the project with an underground-focused exploration model, supported by structural analysis, underground sampling and reassessment of historic drill core to identify higher-grade targets at depth.

The company also owns the Nora silver-gold project in Durango, Mexico, which hosts the historic Candy mine and epithermal vein system that has returned high-grade surface sampling results. In addition, Silver Dollar holds an equity position in Bunker Hill Mining following the sale of the Ranger-Page project, providing equity exposure to the planned production restart in Idaho’s Silver Valley in the first 2026.

Silver Dollar is supported by an experienced management and technical team with expertise in underground exploration, epithermal systems and project evaluation. With a strong treasury, active exploration programs and multiple upcoming catalysts, the company is positioned to deliver exploration progress through 2026.

Company Highlights

  • 100 percent owned La Joya project, an advanced-stage silver-gold-copper system in Mexico’s Durango-Zacatecas silver belt
  • La Joya was originally proposed as an open pit in 2013 based on US$24 silver, US$1,200 gold and US$3 copper
  • Strategic shift toward evaluating La Joya’s high-grade underground potential supported by new 3D geological modeling, underground sampling, and drill target development
  • Completed sale of the Ranger-Page project to Bunker Hill Mining, providing equity exposure to a near-term US silver producer
  • Fully funded to carry out planned exploration programs through 2026
  • Largest shareholder is mining investor Eric Sprott, with approximately 17.5 percent ownership
  • Multiple exploration catalysts planned, including drilling at La Joya in early 2026

Key Projects

La Joya Silver-Gold-Copper Project

The La Joya project is Silver Dollar’s 100 percent owned flagship asset. It is located within the Durango-Zacatecas silver belt, which hosts numerous past-producing and operating mines, including assets operated by First Majestic Silver, Grupo México, Industrias Peñoles and Pan American Silver.

Historical exploration at La Joya outlined multiple zones of mineralization, including the Main Mineralized Trend, Santo Niño and Coloradito, with mineralization occurring as skarn, replacement and vein-style systems. Previous work was largely oriented toward evaluating open-pit potential.

Silver Dollar is advancing a reinterpretation of La Joya as a potential high-grade underground system. Recent work includes:

  • Underground sampling from historic workings, returning values of up to 2,753 grams per metric ton (g/t) silver equivalent
  • Identification of the Central Dyke zone over approximately 770 meters, including a sample returning 3,513 g/t (~124 oz/ton) silver
  • Discovery of the Brazo zone, located approximately 1 kilometer west of the Main Mineralized Trend, with Phase II drilling returning up to 451 g/t silver over 5 meters
  • The Brazo Zone provides evidence of deeper, high-grade mineralization at La Joya
  • Development of new 3D geological models is in progress incorporating the large database of structural, geochemical and fault-kinematic analysis

Silver Dollar plans to advance a new phase of drilling at La Joya in the first quarter of 2026, with a focus on testing high-grade underground targets identified through recent modeling and sampling.

Nora Silver-Gold Project

The Nora project is located in Durango, Mexico, within the same regional silver trend as several major operations. The property hosts an epithermal vein system known as the Candy vein.

Geological mapping and surface sampling have returned high-grade gold, silver and base metal values, including samples grading up to 29.61 g/t gold and 2,215 g/t silver, along with locally elevated copper, lead and zinc values.

In 2025, Silver Dollar identified the North Canyon zone, located approximately 1.5 kilometers north of the historic Candy mine. Channel sampling returned 162 g/t silver equivalent over 12.48 meters within a broad oxidation zone. Ongoing mapping and trenching are being used to define drill targets for potential drill testing in the first quarter of 2026.

Ranger-Page Project (Sold)

Silver Dollar acquired the Ranger-Page silver-lead-zinc project in Idaho’s Silver Valley in August 2024 and agreed to sell the asset to neighbor Bunker Hill Mining in October 2025 for C$3.5 million, payable by the issuance of 23,333,334 Bunker Hill shares at a deemed price of C$0.15 per share. The sale closed in December and the value of those Bunker Hill shares at the time of closing was approximately $5.8 million.

The Ranger-Page project is geologically contiguous with the Bunker Hill mine system. The transaction provides Silver Dollar with equity exposure to Bunker Hill’s planned production restart in the first half of 2026. Teck Resources owns ~32 percent of Bunker Hill and has life-of-mine off-take agreement for 100 percent of the zinc and lead production. Silver Dollar expects Bunker Hill to receive increased analyst coverage and a higher valuation next year as production commences.

Red Lake Area Properties

Silver Dollar also holds two 100 percent owned gold grassroots exploration properties in Ontario’s Red Lake mining division: Pakwash Lake and Longlegged Lake. Early-stage work has included airborne magnetic surveys, geological mapping and surface sampling, identifying structural and geophysical targets associated with the Pakwash Lake Fault Zone.

While not a primary focus, the properties provide optionality in a well-established gold district with major Kinross Gold discovery drilling on the Dixie Halo property that adjoins both properties to the north.

Management Team

Gregory Lytle — President, CEO and Director

Gregory Lytle has more than 20 years of experience advising mineral exploration companies on corporate strategy, capital markets and communications. Prior to becoming CEO in 2025, Lytle served as a consultant to Silver Dollar and has facilitated more than $100 million in financings for mining-sector clients.

J.J. (Jeff) Smulders — CFO, Corporate Secretary and Director

Jeff Smulders has more than 45 years of experience in accounting, taxation and financial management. He has provided financial consulting services to public and private companies for more than 25 years.

Bruce MacLachlan — Independent Director

Bruce MacLachlan is an exploration professional with more than four decades of experience across grassroots and advanced-stage projects. He has worked with companies including Noranda, Hemlo Gold, Battle Mountain and Noront.

Guillermo Lozano-Chávez — Independent Director

Guillermo Lozano-Chávez is a geologist with more than 40 years of experience in exploration and mine management across the Americas. He previously served as vice president of exploration at First Majestic Silver.

Dale Moore — Exploration Manager and Qualified Person

Dale Moore is an underground-focused geologist with more than a decade of experience in Idaho’s Coeur d’Alene Mining District. His work includes major deposits such as Lucky Friday and the Galena Complex, and he leads technical work at La Joya.

Mark Malfair — Country Manager, Mexico

Mark Malfair is a bilingual geologist with more than 25 years of experience in exploration and project management in Mexico, including previous work at Chesapeake Gold’s Metates project.

This post appeared first on investingnews.com
by
Read More
In Investing

First Majestic to Sell Del Toro Silver Mine to Sierra Madre in US$60 Million Deal

No Comments

First Majestic Silver (TSX:AG,NYSE:AG) has agreed to sell its Del Toro Silver Mine in Mexico to Sierra Madre Gold and Silver (TSXV:SM,OTC:SMDRF) in a transaction valued at up to US$60 million.

The Vancouver-based miner said it entered into a definitive agreement on December 17 to divest the 100 percent-owned, past-producing Del Toro mine, located in the halchihuites, Zacatecas region of Mexico.

Under the terms of the agreement, First Majestic will receive US$30 million at closing, consisting of US$20 million in cash and US$10 million in Sierra Madre common shares.

The shares will be issued at a price of C$1.30 each, matching the price of Sierra Madre’s concurrent subscription receipt financing tied to the transaction.

An additional US$30 million may be paid over time if certain development and production benchmarks are met. Within 18 months of closing, Sierra Madre is required to pay US$10 million in either cash or shares, at its election, based on the prevailing market price at the time of issuance and subject to a cap on the number of shares issued.

Further payments of US$10 million each are tied to the delineation of at least 100 million silver-equivalent ounces in mineral resources within 48 months, including the achievement of sustained commercial production of at least 4,000 tonnes per day within 60 months of closing.

All shares issued to First Majestic will be subject to statutory hold periods and additional resale restrictions under the agreement.

The transaction is conditional on Sierra Madre completing a concurrent private placement financing of at least USD$29 million in gross proceeds.

The company has announced plans to raise up to C$50 million through the issuance of subscription receipts, with the financing expected to close in January 2026.

Completion of the sale is also subject to customary regulatory and shareholder approvals. Sierra Madre expects to seek shareholder approval for the acquisition by the end of April 2026.

Del Toro is a former silver, gold, and lead producer that was placed on care and maintenance by First Majestic in January 2020.

The sale follows a prior transaction between the two companies, after Sierra Madre acquired the La Guitarra Silver Mine from First Majestic in 2022 and brought it back into commercial production in January 2025.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com
by
Read More